References
- 1. Muttray A, Geißler B, Letzel S. Kollaborierende Roboter – eine Herausforderung auch für den Betriebsarzt [Collaborative robots – a challenge for the company doctor, in German]. Arbeitsmed Sozialmed Umweltmed 2012;33:591–7.
- 2. Palmen NGM, Verbist KJM. Prioritization of new and emerging chemical risks for workers and follow-up actions. RIVM Report 2015–0091 [displayed 28 March 2019]. Available at http://rivm.openrepository.com/rivm/bitstream/10029/559415/3/2015-0091.pdf
- 3. European Agency for Safety and Health at Work: Brun E. Expert Forecast on Emerging Chemical Risks Related to Occupational Safety and Health, 2009 [displayed 28 March 2019]. Available at https://osha.europa.eu/en/tools-and-publications/publications/reports/TE3008390ENC_chemical_risks
- 4. Muttray A, Schneider M, Letzel S. Intoxication with a tropenol ester. Occup Med (Lond) 2012;62:305–7. doi: 10.1093/occmed/kqs032
- 5. Li J, Liu KK. Synthetic approaches to the 2002 new drugs. Mini Rev Med Chem 2004;4:207–33. doi: 10.2174/1389557043487457
- 6. Muttray A, Maier W, Vogt T, Demuth W, Konietzko J. Enzephalopathie nach Intoxikation mit einem Anticholinergikum [Encephalopathy after intoxication with an anticholinergic substance, in German]. Dtsch Med Wochenschr 1994;119:731–4. doi: 10.1055/s-2008-1058754
- 7. Ippen H. Comment on: Enzephalopathie nach Intoxikation mit einem Anticholinergikum [Encephalopathy following poisoning with an anticholinergic agent, in German]. Dtsch Med Wochenschr 1994;119:1803. PMID: 7736940
- 8. Bader M, Barr D, Göen Th, Schaller KH, Scherer G, Angerer J. Reliability criteria for analytical methods. In: Angerer J, Hartwig A, editors. The MAK-collection for occupational health and safety Part IV: Biomonitoring methods. Vol. 12, 2010 [displayed 28 March 2019]. Available at https://onlinelibrary.wiley.com/doi/abs/10.1002/3527600418.bireliabe0012
- 9. Wagner M. Biomonitoring in der betriebsärztlichen Praxis [Biomonitoring in occupational medicine, in German]. Zbl Arbeitsmed 2016;66:266–71. doi: 10.1007/s40664-016-0133-5
- 10. Rumack BH, Lovejoy FH. Clinical toxicology. In: Klaasen CD, Amdur MO, Doull J, editors. Casarett and Doull’s Toxicology. New York: Macmillan Publishing Company; 1986. p. 879–901.
- 11. Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 2000;44:551–60. doi: 10.1016/S0003-4878(00)00050-8
- 12. Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg 2014;11:728–40. doi: 10.1080/15459624.2014.916809
- 13. Lauwerys RR, Hoet P. Introduction. Definition and objectives of biological monitoring of exposure to industrial chemicals. In: Lauwerys RR, Hoet P, editors. Industrial chemical exposure: guidelines for biological monitoring. Boca Raton: CRC Press; 2001. p. 1–19.
- 14. Grando SA, Kawashima K, Kirkpatrick CJ, Kummer W, Wessler I. Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system. Int Immunopharmacol 2015;29:1–7. doi: 10.1016/j.intimp.2015.08.023
- 15. Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K, Kawashima K. Physiological functions of the cholinergic system in immune cells. J Pharmacol Sci 2017;134:1–21. doi: 10.1016/j.jphs.2017.05.002
- 16. Muttray A, Scharnbacher J. Bedeutung der Arbeitsplatzanalyse für die Begutachtung und Prävention am Beispiel einer chronischen Bleiintoxikation [Importance of workplace analysis for assessment and prevention: an example of chronic lead poisioning, in German]. Arbeitsmed Sozialmed Umweltmed 2008;43:618–21.